Accès gratuit
Med Sci (Paris)
Volume 19, Numéro 1, Janvier 2003
Page(s) 71 - 76
Section M/S Revues
Publié en ligne 15 janvier 2003
  1. Sorimachi H, Suzuki K. The structure of calpain. J Biochem 2001; 129: 653–64. [Google Scholar]
  2. Glading A, Lauffenburger DA, Wells A. Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol 2002; 12 : 46–54. [Google Scholar]
  3. Sato K, Kawashima S. Calpain function in the modulation of signal transduction molecules. Biol Chem 2001; 382: 743–51. [Google Scholar]
  4. Arthur JSC, Elce JS, Hegadorn C, Williams K, Greer PA. Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol Cell Biol 2000; 20: 4474–81. [Google Scholar]
  5. Azam M, Andrabi SS, Sahr KE, Kamath L, Kuliopulos A, Chishti AH. Disruption of the mouse m-calpain gene reveals an essential role in platelet function. Mol Cell Biol 2001; 21: 2213–20. [Google Scholar]
  6. Permutt MA, Bernal- Mizrachi E, Inoue H. Calpain 10: the first positional cloning of a gene for type 2 diabetes? J Clin Invest 2000; 106: 819–21. [Google Scholar]
  7. Baghdiguian S, Martin M, Richard I, et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkBa/NF-kB pathway in limb-girdle muscular dystrophy type 2A. Nature Med 1999; 5: 503–11. [Google Scholar]
  8. Richard I, Roudaut C, Marchand S, et al. Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IқBa/nuclear factor қB pathway perturbation in mice. J Cell Biol 2000; 151: 1583–90. [Google Scholar]
  9. Shumway SD, Maki M, Miyamoto S. The PEST domain of IқBa is necessary and sufficient for in vitro degradation by m-calpain. J Biol Chem 1999; 274: 30874–81. [Google Scholar]
  10. Chen F, Demers LM, Vallyathan V, Lu Y, Castranova V, Shi X. Impairment of NF-қB activation and modulation of gene expression by calpastatin. Am J Physiol 2000; 279: C709–16. [Google Scholar]
  11. McDonald MC, Mota-Filipe H, Paul A, et al. Calpain inhibitor I reduces the activation of nuclear factor-κB and organ injury/dysfunction in hemorragic shock. FASEB J 2001; 15: 171–86. [Google Scholar]
  12. Cuzzocrea S, McDonald MC, Mazzon E, et al. Calpain inhibitor I reduces the development of acute and chronic inflammation. Am J Pathol 2000; 157: 2065–79. [Google Scholar]
  13. Cuzzocrea S, McDonald MC, Mazzon E, et al. Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat. Gut 2001; 48: 478–88. [Google Scholar]
  14. Cox EA, Huttenlocher A. Regulation of integrinmediated adhesion during cell migration. Microsc Res Tech 1998; 43: 412–9. [Google Scholar]
  15. Pontremoli S, Melloni E, Damiani G, et al. Effects of a monoclonal anti-calpain antibody on responses of stimulated human neutrophils. Evidence for a role for proteolytically modified protein kinase C. J Biol Chem 1988; 263: 1915–9. [Google Scholar]
  16. Kavita U, Mizel SB. Differential sensitivity of interleukin-1 alpha and - beta precursor proteins to cleavage by calpain, a calcium-dependent protease. J Biol Chem 1995; 270: 27758–65. [Google Scholar]
  17. Bellocq A, Doublier S, Suberville S, et al. Somatostatin increases glucocorticoid binding and signaling in macrophages by blocking the calpainspecific cleavage of Hsp 90. J Biol Chem 1999; 274: 36891–6. [Google Scholar]
  18. Knepper-Nicolai B, Savill J, Brown SB. Constitutive apoptosis in human neutrophils requires synergy between calpains and the proteasome downstream of caspases. J Biol Chem 1998; 273: 30530–6. [Google Scholar]
  19. Wang KK. Calpain and caspase: can you tell the difference? Trends Neurosci 2000; 23 : 20–6. [Google Scholar]
  20. Liu X, Rainey JJ, Harriman JF, Schnellmann RG. Calpains mediate acute renal cell death: role of autolysis and translocation. Am J Physiol 2001; 281: F728–38. [Google Scholar]
  21. Szomor Z, Shimizu K, Yamamoto S, Yasuda T, Ishikawa H, Nakamura T. Externalization of calpain (calciumdependent neutral cysteine proteinase) in human arthritic cartilage. Clin Exp Rheumatol 1999; 17: 569–74. [Google Scholar]
  22. Deshpande RV, Goust JM, Chakrabarti AK, Barbosa E, Hogan EL, Banik NL. Calpain expression in lymphoid cells. Increased mRNA and protein levels after cell activation. J Biol Chem 1995; 270: 2497–505. [Google Scholar]
  23. Kunimatsu M, Ma XJ, Nishimura J, et al. Neutrophil chemotactic activity of N-terminal peptides from the calpain small subunit. Biochem Biophys Res Commun 1990; 169: 1242–7. [Google Scholar]
  24. Abe M, Oda N, Sato Y. Cellassociated activation of latent transforming growth factor-β by calpain. J Cell Physiol 1998; 174: 186–93. [Google Scholar]
  25. Loew D, Perrault C, Morales M, et al. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Biochemistry 2000; 39: 10812–22. [Google Scholar]
  26. Mimory T, Suganuma K, Tanami Y, et al. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases. Proc Natl Acad Sci USA 1995; 92: 7267–71. [Google Scholar]
  27. Vanderklish PW, Bahr BA. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int J Exp Pathol 2000; 81: 323–39. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.